Avoidable cancer deaths globally.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Works matching IS 00079235 AND DT 2011 AND VI 61 AND IP 2
Results: 10
1
2
Discontinuation of imatinib may be possible in chronic myelogenous leukemia.
- Published in:
- CA: A Cancer Journal for Clinicians, 2011, v. 61, n. 2, p. 65, doi. 10.3322/caac.20110
- By:
- Publication type:
- Article
3
Global cancer statistics.
- Published in:
- CA: A Cancer Journal for Clinicians, 2011, v. 61, n. 2, p. 69, doi. 10.3322/caac.20107
- By:
- Publication type:
- Article
4
Lung cancer: New biological insights and recent therapeutic advances.
- Published in:
- CA: A Cancer Journal for Clinicians, 2011, v. 61, n. 2, p. 91, doi. 10.3322/caac.20102
- By:
- Publication type:
- Article
5
Erratum: Cancer Statistics, 2010.
- Published in:
- 2011
- Publication type:
- Erratum
6
Erratum: Cancer Statistics, 2010.
- Published in:
- 2011
- Publication type:
- Erratum
7
Surgical management of malignant colonic polyps often suboptimal.
- Published in:
- CA: A Cancer Journal for Clinicians, 2011, v. 61, n. 2, p. 63, doi. 10.3322/caac.20109
- By:
- Publication type:
- Article
8
Erratum: Inflammatory Breast Cancer: The Disease, The Biology, The Treatment.
- Published in:
- 2011
- Publication type:
- Erratum
9
Erratum: Global Cancer Statistics.
- Published in:
- 2011
- Publication type:
- Erratum
10
Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors.
- Published in:
- CA: A Cancer Journal for Clinicians, 2011, v. 61, n. 2, p. 113, doi. 10.3322/caac.20097
- By:
- Publication type:
- Article